natgillin/translations-raw huggingface dataset:
Hvis atazanavir/ritonavir administreres samtidigt med både tenofovirdisoproxilfumarat og en H2-receptorantagonist, anbefales dosisøgning af atazanavir til 400 mg med 100 mg ritonavir. 
If atazanavir/ritonavir with both tenofovir disoproxil fumarate and an H2-receptor antagonist are co-administered, a dose increase of atazanavir to 400 mg with 100 mg of ritonavir is recommended.
Pravastatin metaboliseres ikke af CYP3A4. 
Pravastatin is not metabolised by CYP3A4.
Ved administration sammen med tenofovirdisoproxilfumarat anbefales det at give atazanavir 300 mg med ritonavir 100 mg og tenofovirdisoproxilfumarat 300 mg (alle som en enkeltdosis sammen med mad). 
When co-administered with tenofovir disoproxil fumarate, it is recommended that atazanavir 300 mg be given with ritonavir 100 mg and tenofovir disoproxil fumarate 300 mg (all as a single dose with food).
Lamotrigin bør anvendes med forsigtighed sammen med atazanavir/ritonavir. 
Lamotrigine should be used with caution in combination with atazanavir/ritonavir.
Voriconazol AUC ↑561% (↑451% 
Voriconazole AUC ↑561% (↑451%
Der er ikke set signifikant påvirkning af methadon-koncentrationen. 
No significant effect on methadone concentrations was observed.
60 hårde kapsler. 
60 hard capsules.
Blandt behandlingsnaive patienter, der fik atazanavir 300 mg én gang dagligt med 100 mg ritonavir én gang dagligt med en middel-behandlingsvarighed på 96 uger, havde 48% grad 3-4 forhøjelse af total bilirubin (se pkt. 
Among naive patients treated with atazanavir 300 mg once daily with 100 mg ritonavir once daily for a median duration of 96 weeks, 48% had Grade 3-4 total bilirubin elevations (see section 4.4).
Samtidig administration med produkter indeholdende grazoprevir, inklusive fastdosis kombination af elbasvir/grazoprevir (bruges til behandling af kronisk hepatitis C infektion) (se pkt. 
Co-administration with grazoprevir-containing products, including elbasvir/grazoprevir fixed dose combination (used to treat chronic hepatitis C infection) (see section 4.5).
60 × 1 hårde kapsler. 
60 x 1 hard capsules.
Samtidig administration af atazanavir/ritonavir og disse glukokortikoider frarådes, medmindre den potentielle fordel ved behandlingen opvejer risikoen for systemiske bivirkninger (se pkt. 
Co- administration of atazanavir /ritonavir and these glucocorticoids is not recommended unless the potential benefit of treatment outweighs the risk of systemic corticosteroid effects (see section 4.4).
Denne effekt kan skyldes CYP3A4-induktion. 
This effect may be due to an induction of CYP3A4.
Tabel 8: Steady state farmakokinetik af atazanavir med ritonavir hos HIV-smittede gravide kvinder efter fødeindtagelse 
Table 8: Steady-State Pharmacokinetics of Atazanavir with ritonavir in HIV-Infected Pregnant Women in the Fed State atazanavir 300 mg with ritonavir 100 mg
Voriconazol Cmin ↑765% (↑571% 
Voriconazole Cmin ↑765% (↑571%
Der er rapporteret tilfælde af osteonekrose hos patienter med fremskreden HIV-sygdom og/eller patienter i langvarig kombinationsbehandling med antiretrovirale lægemidler (CART). 
Cases of osteonecrosis have been reported, particularly in patients with generally acknowledged risk factors, advanced HIV disease or long- term exposure to combination antiretroviral therapy (CART).
Enkeltdosis af famotidin bør aldrig overstige 20 mg, og den totale daglige dosis af famotidin bør ikke overstige 40 mg. at det er nødvendigt at tage højde for, at samtidig administration af voriconazol og atazanavir uden ritonavir kan påvirke koncentrationen af atazanavir samtidig administration af fluticason og atazanavir uden ritonavir kan øge koncentrationen af fluticason i forhold til administration af fluticason alene ved samtidig administration af et oralt kontraceptivum og atazanavir uden ritonavir, anbefales det, at det orale kontraceptivum indeholder højst 30 µg ethinylestradiol dosisjustering af lamotrigin ikke er nødvendig 
• the need to consider that - co-administration of voriconazole and atazanavir without ritonavir may affect atazanavir concentrations - co-administration of fluticasone and atazanavir without ritonavir may increase fluticasone concentrations relative to fluticasone given alone - if an oral contraceptive is administered with atazanavir without ritonavir, it is recommended that the oral contraceptive contain no more than 30 µg of ethinyloestradiol - no dose adjustment of lamotrigine is required
Da atazanavir hæmmer CYP3A4 forventes koncentrationen af quetiapin at stige. 
Due to CYP3A4 inhibition by atazanavir, concentrations of quetiapine are expected to increase.
Tag ikke Atazanavir Mylan : hvis du er allergisk over for atazanavir eller et af de øvrige indholdsstoffer i Atazanavir Mylan (angivet i afsnit 6). 
• if you are allergic to atazanavir or any of the other ingredients of this medicine (listed in section 6)
Lægen kan vælge at justere dosis af Atazanavir Mylan , hvis det er relevant i forhold til din behandling. 
Your doctor may adjust the dose of Atazanavir Mylan according to your anti-HIV therapy.
Atazanavir med ritonavir har ikke været undersøgt hos patienter med nedsat leverfunktion. 
Atazanavir with ritonavir has not been studied in patients with hepatic impairment.
Interaktionsmekanismen er CYP3A4og UGT1A1-hæmning. 
The mechanism of interaction is CYP3A4 and UGT1A1 inhibition.
Voriconazol AUC ↓33% (↓42% 
Voriconazole AUC ↓33% (↓42%
produkter indeholdende grazoprevir, inklusive elbasvir/gazoprevir i fastdosis-kombination (bruges til behandling af kronisk hepatitis C infektion) 
• grazoprevir-containing products, including elbasvir/grazoprevir fixed dose combination (used to treat chronic hepatitis C infection).
angioødema, urticaria, alopeci, pruritus sjælden: Stevens-Johnsons syndroma,b, vesikulobulløst udslæt, eksem, vasodilatation 
, angioedema a, urticaria, alopecia, pruritus; rare: Stevens-Johnson syndrome a,b
Sildenafil er kontraindiceret ved behandling af pulmonal arteriel hypertension (se pkt. 
Sildenafil, when used for the treatment of pulmonary arterial hypertension, is contraindicated (see section
Post partum 
During postpartum
Samtidig administration af præparater, der indeholder perikon (Hypericum perforatum) (se pkt. 
Co-administration with products containing St. John's wort (Hypericum perforatum) (see section 4.5).
Samtidig administration af atazanavir med ritonavir og en protonpumpehæmmer frarådes. 
Co-administration of atazanavir with ritonavir and proton pump inhibitors is not recommended.
Det skal du vide, før du begynder at tage Atazanavir Mylan 3. 
What you need to know before you take Atazanavir Mylan 3.
Samtidig administration af simvastatin eller lovastatin og atazanavir er kontraindiceret på grund af øget risiko for myopati, inklusive rabdomyolyse (se pkt. 
Co-administration of simvastatin or lovastatin with atazanavir is contraindicated due to an increased risk of myopathy including rhabdomyolysis (see section 4.3).
Der er rapporteret om hududslæt og kløe, som i nogle tilfælde kan være alvorligt. 
• Skin rash, itching that may occasionally be severe has been reported.
30 x 1 hård kapsel. 
30 x 1 hard capsules.
Stevens-Johnsons syndrom (SJS), erythema multiforme, toksiske huderuptioner og lægemiddelfremkaldt udslæt med eosinofili og systemiske symptomer (DRESS-syndrom) har været rapporteret hos patienter i behandling med atazanavir (se pkt. 
Stevens-Johnson syndrome (SJS), erythema multiforme, toxic skin eruptions and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome have been reported with the use of atazanavir (see section 4.4).
Gennemsnitlig halveringstid var, inden for atazanavirs dosisinterval, hos HIV-inficerede voksne patienter (n=33, kombinerede studier) 12 timer ved steady state efter en dosis på 300 mg dagligt med 100 mg ritonavir én gang dagligt med et let måltid. 
In HIV-infected adult patients (n=33, combined studies) the mean half-life within a dosing interval for atazanavir was 12 hours at steady state following a dose of 300 mg daily with ritonavir 100 mg once daily with a light meal.
Patienter i behandling med Atazanavir Mylan, som har forhøjede levertransaminaser og forhøjet bilirubin samtidig, bør evalueres for alternative ætiologier. 
Hepatic transaminase elevations that occur with elevated bilirubin in patients receiving Atazanavir Mylan should be evaluated for alternative aetiologies.
Hos et lille antal patienter uden en funktionel CYP2C19-allel forventes signifikant øget eksponering for voriconazol. 
In a small number of patients without a functional CYP2C19 allele, significantly increased voriconazole exposures are expected.
Der kan hos nogle patienter med fremskreden HIV-infektion (AIDS) og med tidligere infektion, som skyldes nedsat immunforsvar, opstå tegn og symptomer på betændelse fra tidligere infektioner. 
In some patients with advanced HIV infection (AIDS) and a history of opportunistic infection, signs and symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started.
Der er ikke set signifikant påvirkning af atazanavir-koncentrationen. 
No significant effect on atazanavir concentrations was observed.
Samtidig administration af atazanavir kan medføre øget koncentration af PDE5hæmmeren og øget risiko for PDE5relaterede bivirkninger, inklusive hypotension, synsforstyrrelser og priapisme. 
Co-administration with atazanavir may result in increased concentrations of the PDE5 inhibitor and an increase in PDE5-associated adverse events, including hypotension, visual changes, and priapism.
Samtidig administration af atazanavir og triazolam eller oralt administreret midazolam er kontraindiceret (se pkt. 
Co-administration of atazanavir with triazolam or orally administered midazolam is contraindicated (see section 4.3),
Samtidig administration af Atazanavir Mylan og nevirapin eller efavirenz frarådes (se pkt. 
Co-administration of Atazanavir Mylan with nevirapine or efavirenz is not recommended (see section 4.5).
Kapslerne bør synkes hele. 
The capsules should be swallowed whole.
Samtidig administration af atorvastatin og atazanavir frarådes. 
Co-administration of atorvastatin with atazanavir is not recommended.
Indinavir resulterer i indirekte ukonjugeret hyperbilirubinæmi på pga. UGT-hæmning. 
Indinavir is associated with indirect unconjugated hyperbilirubinaemia due to inhibition of UGT.
Samtidig administration af stavudin og atazanavir forventes ikke at påvirke stavudineksponeringen signifikant. 
The co-administration of stavudine with atazanavir is not expected to significantly alter the exposure of stavudine.
Atazanavir metaboliseres hovedsageligt af CYP3A4. 
Atazanavir is metabolised principally by CYP3A4.
Samtidig administration af bepridil er kontraindiceret (se pkt. 
Co-administration with bepridil is contraindicated (see section 4.3)
Ritonavir anvendes som farmakokinetisk booster for atazanavir (se pkt. 
Ritonavir is used as a booster of atazanavir pharmacokinetics (see sections 4.5 and 5.1).
* Sammenlignet med Atazanavir 300 mg/ritonavir 100 mg én gang dagligt om aftenen uden efavirenz. 
* When compared to Atazanavir 300 mg/ritonavir 100 mg once daily in the evening without efavirenz.
Sådan skal du tage Atazanavir Mylan 4. 
How to take Atazanavir Mylan 4.
Atazanavir metaboliseres primært via leveren, og der er observeret forhøjet plasmakoncentration hos patienter med nedsat leverfunktion (se pkt. 
Atazanavir is primarily hepatically metabolised and increased plasma concentrations were observed in patients with hepatic impairment (see sections 4.2 and 4.3).
Efter en 26-30 ugers induktionsfase med atazanavir 300 mg + ritonavir 100 mg en gang dagligt og to NRTI'er havde ikke-boostet atazanavir 400 mg en gang dagligt og to NRTI'er, som blev administreret i en 48-ugers vedligeholdelsesfase (n=87) i et åbent, randomiseret, komparativt studie, samme antivirale virkning som atazanavir + ritonavir og to NRTI'er (n=85) hos HIV-inficerede forsøgspersoner med fuldt supprimeret hiv-replikation. 
In an open-label, randomised, comparative study following a 26- to 30-week induction phase with atazanavir 300 mg + ritonavir 100 mg once daily and two NRTIs, unboosted atazanavir 400 mg once daily and two NRTIs administered during a 48-week maintenance phase (n=87) had similar antiviral efficacy compared with atazanavir + ritonavir and two NRTIs (n=85) in HIV infected subjects with fully suppressed HIV replication, as assessed by the proportion of subjects with HIV RNA < 50 copies/ml: 78% of subjects on unboosted atazanavir and two NRTIs compared with 75% on atazanavir + ritonavir and two NRTIs.
14-OH-clarithromycin 14-OH-clarithromycin AUC ↓70% 
14-OH clarithromycin AUC ↓70%
Dosisjustering er ikke nødvendig for atazanavir. 
No dose adjustment is needed for atazanavir.
* Sammenlignet med atazanavir 300 mg/ritonavir 100 mg uden nevirapin. 
* When compared to atazanavir 300 mg and ritonavir 100 mg without nevirapine.
Atazanavir (morgen): 2 timer efter omeprazol 
Atazanavir (am): 2 hr after omeprazole
Atazanavir Mylan indeholder lactose. 
Atazanavir Mylan contains lactose
Det hæmmer CYP3A4. 
It inhibits CYP3A4.
Samtidig administration af voriconazol og atazanavir med ritonavir frarådes medmindre det vurderes, at fordel/risikoforholdet for patienten berettiger brug af voriconazol (se pkt. 
Co-administration of voriconazole and atazanavir with ritonavir is not recommended unless an assessment of the benefit/risk to the patient justifies the use of voriconazole (see section 4.4).
Midazolam og triazolam metaboliseres i udstrakt grad af CYP3A4. 
Midazolam and triazolam are extensively metabolised by CYP3A4.
4.2 og 4.4). 
(See sections 4.2 and 4.4.)
Hver kapsel indeholder 112 mg lactosemonohydrat. 
Each capsule contains 112 mg lactose monohydrate
Hvis du holder op med at tage Atazanavir Mylan 
If you stop taking Atazanavir Mylan
Disse lægemidler er nævnt i starten af afsnit 2 Brug ikke Atazanavir Mylan. 
These are listed under Do not take Atazanavir Mylan, at the start of Section 2.
Kontakt lægen, før du tager denne medicin, hvis lægen har fortalt dig, at du ikke tåler visse sukkerarter (f.eks. lactose). 
If you have been told by your doctor that you have an intolerance to some sugars (e.g. lactose), contact your doctor before taking this medicinal product.
Atazanavir må ikke anvendes til patienter med svært nedsat leverfunktion. 
Unboosted atazanavir must not be used in patients with severe hepatic impairment.
Famotidin 20 mg 2 gange dagligt 
Omeprazole 20 mg once daily
På grund af phenytoins/phenobarbitals inducerende effekt kan nedsat eksponering for atazanavir ikke udelukkes. 
Due to phenytoin/phenobarbital inducing effect, a reduction in atazanavir exposure cannot be ruled out combination with atazanavir /ritonavir.
* Sammenlignet med atazanavir 300 mg 1 gang dagligt med ritonavir 100 mg 1 gang dagligt og tenofovirdisoproxilfumarat 300 mg, alle som enkeltdosis med mad. 
* When compared to atazanavir 300 mg once daily with ritonavir 100 mg once daily and tenofovir disoproxil fumarate 300 mg all as a single dose with food.
Koncentration af disse immunsuppressiva kan øges ved samtidig administration af atazanavir pga. CYP3A4-hæmning. 
Concentrations of these immunosuppressants may be increased when co-administered with atazanavir due to CYP3A4 inhibition.
Hvis du har glemt at tage Atazanavir Mylan 
If you forget to take Atazanavir Mylan
Behandlingsnaive atazanavirkapsler/ritonavir (300 mg/100 mg én gang dagligt) n=16 
Treatment-Naive Atazanavir Capsules/ritonavir (300 mg/100 mg once daily) n=16
V82AFLST, I84V, N88DS, L90M; PI minor: L10CFIRV, V11I, E35G, K43T, Q58E, A71ILTV, G73ACST, T74P, N83D, L89V. 
PI major L24I, D30N, V32I, L33F, M46IL, I47AV, G48V, I50LV, F53LY,I54ALMSTV, L76V, V82AFLST, I84V, N88DS, L90M; PI minor: L10CFIRV, V11I, E35G, K43T, Q58E, A71ILTV, G73ACST, T74P, N83D, L89V.
Interaktionsmekanismen er nedsat opløselighed af atazanavir pga. intragastrisk pH-stigning med protonpumpehæmmere. 
The mechanism of interaction is decreased solubility of atazanavir as intra-gastric pH increases with proton pump inhibitors.
Yderligere mindre metaboliske pathways består af N-dealkylering og hydrolyse. 
Additional minor metabolic pathways consist of
Ved kliniske fund (f.eks. bradykardi) anbefales kardial monitorering. 
Cardiac monitoring is recommended based on the presence of clinical findings (e.g., bradycardia).
rifampicin, et antibiotikum, der bruges til at behandle tuberkulose astemizol eller terfenadin (bruges almindeligvis til at behandle allergiske symptomer, det er medicin som muligvis kan fås uden recept); cisaprid (bruges til at behandle tilbageløb af maveindhold, nogle gange omtalt som sure opstød); pimozid (bruges til at behandle skizofreni); quinidin eller bepridil (bruges til at korrigere hjerterytme); ergotamin, dihydroergotamin, ergonovin, methylergonovin (bruges til at behandle migræne); og alfuzosin (bruges til at behandle forstørret blærehalskirtel (prostata)) 
• if you are taking any of these medicines: see also Other medicines and Atazanavir Mylan - rifampicin, an antibiotic used to treat tuberculosis - astemizole or terfenadine (commonly used to treat allergy symptoms, these medicines may be available without prescription); cisapride (used to treat gastric reflux, sometimes called heartburn); pimozide (used to treat schizophrenia); quinidine or bepridil (used to correct heart rhythm); ergotamine, dihydroergotamine, ergonovine, methylergonovine (used to treat headaches); and alfuzosin (used to treat enlarged prostatic gland).
Børn under 3 måneder og som vejer under 5 kg må ikke få denne medicin. 
Do not give this medicine to children younger than 3 months of age and weighing less than 5 kg.
Den anbefalede dosis til voksne er 300 mg én gang dagligt sammen med 100 mg ritonavir én gang dagligt i forbindelse med et måltid og i kombination med anden HIV-medicin. 
The recommended dose of Atazanavir Mylan capsules for adults is 300 mg once daily with 100 mg ritonavir once daily, taken with food, in combination with other anti-HIV medicines.
For de behandlingserfarne pædiatriske patienter var middel-baseline-CD4-celletal 522 celler/mm3 (interval 100-1.157 celler/ 
For treatment-experienced paediatric patients, the mean baseline CD4 cell count was 522 cells/mm
Atazanavir uden ritonavir bør ikke overvejes hos patienter, der bliver behandlet i et baggrundsprogram med tenofovirdisoproxil og med andre samtidige lægemidler, der reducerer atazanavirs biotilgængelighed (se pkt. 
Atazanavir given without ritonavir should not be considered in patients treated with a backbone regimen containing tenofovir disoproxil and with other concomitant medications that reduce atazanavir bioavailability (see section 4.5 In case of withdrawal of ritonavir from the recommended atazanavir boosted regimen) or in case of perceived challenging compliance.
Hver kapsel indeholder 168 mg lactosemonohydrat. 
Each capsule contains 168 mg lactose monohydrate
Atazanavir metaboliseres i leveren gennem CYP3A4. 
Atazanavir is metabolised in the liver through CYP3A4.
Brug af anden medicin sammen med Atazanavir Mylan Du må ikke tage Atazanavir Mylan sammen med visse andre lægemidler. 
You must not take Atazanavir Mylan with certain medicines.
Koncentrationerne af grazoprevir steg betydeligt ved samtidig administration med atazanavir/ritonavir. 
Grazoprevir concentrations were greatly increased when co-administered with atazanavir/ritonavir.
Samtidig administration af lægemidler, der er substrat for CYP3A4 isoformen af cytokrom P450 og har et snævert terapeutisk vindue (f.eks. quetiapin, lurasidon, alfuzosin, astemizol, terfenadin, cisaprid, pimozid, quinidin, bepridil, triazolam og midazolam administreret oralt (se pkt. 
Co-administration with medicinal products that are substrates of the CYP3A4 isoform of cytochrome P450 and have narrow therapeutic windows (e.g., quetiapine, lurasidone, alfuzosin, astemizole, terfenadine, cisapride, pimozide, quinidine, bepridil, triazolam, midazolam administered orally (for caution on parenterally administered midazolam, see section 4.5), and ergot alkaloids, particularly, ergotamine, dihydroergotamine, ergonovine, methylergonovine) (see section 4.5).
Atazanavir forventes at øge plasmakoncentrationen af lurasidon på grund af CYP3A4-hæmning. 
Atazanavir is expected to increase plasma levels of lurasidone due to CYP3A4 inhibition.
Atazanavir Mylan indeholder: 
What Atazanavir Mylan contains
Titandioxid (E171) Indigotin (E132) Gelatine 
Titanium dioxide (E171) Indigo Carmine (E132) Gelatin
Tiden til udbrud er imidlertid mere variabel, og udbrud kan optræde mange måneder efter behandlingsstart. 
however, the reported time to onset is more variable and these events can occur many months after initiation of treatment (see section 4.4).
Liste i tabelform over bivirkninger i tabelform 
Tabulated list of adverse reactions
Atazanavir (morgen): 1 time efter omeprazol 
Atazanavir (am): 1 hr after omeprazole
Samtidig administration af salmeterol og Atazanavir Mylan anbefales ikke (se pkt. 
Co-administration of salmeterol and Atazanavir Mylan is not recommended (see section 4.5).
Kontakt lægen, hvis du lægger mærke til ændringer i helbredet. 
Tell your doctor if you notice anything unusual about your health.
Hver kapsel indeholder 84 mg lactosemonohydrat. 
Each capsule contains 84 mg lactose monohydrate
300 mg kapsler 
300 mg capsules
almindelig: gulsot ikke almindelig: hepatitis, cholelithiasisa, kolestasea sjælden: hepatosplenomegali, cholecystitisa 
common: jaundice; uncommon: hepatitis, cholelithiasis a, cholestasis a;
200 mg kapsler 
200 mg capsules
Hos et lille antal patienter uden en funktionel CYP2C19-allel forventes signifikant øget voriconazoleksponering (se pkt. 
In a small number of patients without a functional CYP2C19 allele, significantly increased voriconazole exposures are expected (see section 4.5).
Voksne patienter, der tidligere har været i antiretroviral behandling 
In antiretroviral experienced adult patients
Må ikke opbevares ved temperaturer over 25°C. 
Store below 25°C.
Der er anden medicin, som du ikke må tage samtidig med Atazanavir Mylan. 
There are other medicines that may not mix with Atazanavir Mylan.
HIV-RNA <50 kopier/ml, % Alle patienterd 
HIV RNA <50 copies/ml, % All patients d
Gentagne doser af atazanavir 300 mg én gang dagligt i kombination med ritonavir 100 mg én gang dagligt sammen med et måltid gav hos HIV-inficerede patienter (n=33, kombinerede studier) et geometrisk gennemsnit (CV%) for atazanavir, Cmax på 4.466 (42%) ng/ml, med en tid til Cmax på ca. 2,5 timer. 
In HIV-infected patients (n=33, combined studies), multiple dosing of atazanavir 300 mg once daily with ritonavir 100 mg once daily with food produced a geometric mean (CV%) for atazanavir, Cmax of 4466 (42%) ng/ml, with time to Cmax of approximately 2.5 hours.
ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ Oral anvendelse. 
METHOD AND ROUTE OF ADMINISTRATION
M36, M46, I54, A71, V82 10-20% L10, I15, K20, V32, E35, S37, F53, I62, G73, I84, L90 a Antal patienter med parvise genotyper, der er klassificeret som virologisk svigt (HIV-RNA 
M36, M46, I54, A71, V82 L10, I15, K20, V32, E35, S37, F53, I62, G73, I84, L90
Atazanavir kan øge plasmakoncentrationen af carbamazepin på grund af CYP3A4hæmning. 
Atazanavir may increase plasma levels of carbamazepine due to CYP3A4 inhibition.
UNIKT ID - 2D-STREGKODE 2D-stregkode med det unikke id 18. 
2D barcode carrying the unique identifier included
Mekanismen for denne interaktion er CYP3A4-hæmning. 
The mechanism of this interaction is CYP3A4 inhibition.
Serumkoncentrationen af verapamil kan øges af atazanavir pga. CYP3A4hæmning. 
Serum concentrations of verapamil may be increased by atazanavir due to CYP3A4 inhibition.
Titandioxid (E171) Patent blue V (E131) Gelatine 
Titanium dioxide (E171) Patent blue V (E131) Gelatin
For de behandlingsnaive pædiatriske patienter var middelbaseline-CD4-celletal 344 celler/mm3 (interval 2-800 celler/mm3), og middel-baseline-plasma HIV-1 
For treatment-naive paediatric patients, the mean baseline CD4 cell count was 344 cells/mm
Dosisjustering er ikke nødvendig ved samtidig administration af methadon og atazanavir. 
No dosage adjustment is necessary if methadone is co-administered with atazanavir.
* Sammenlignet med atazanavir 300 mg 1 gang dagligt med ritonavir 100 mg 1 gang dagligt. 
* When compared to atazanavir 300 mg once daily with ritonavir 100 mg once daily.